Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review
February 2019
60
About the Report
About the Report
Lonza Group Ltd (LONN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Lonza Group Ltd (Lonza) is a provider of contract manufacturing and development solutions to life-science industry. The company offers services including, commercial mammalian and microbial manufacturing, clinical development and manufacturing. It also offers high potential active pharmaceutical ingredients, cell and gene therapy capabilities, advanced intermediates, oral drug product development services, cell-culture modeling, genome editing, endotoxin products, and research media and testing products. Lonza provides solutions for health and well-being, microbial and hygiene control, and composites and material protection. Lonza serves biotechnology, pharmaceutical, academic, and government research industries; manufacturers of health and consumer products; formulators and service companies. The company operates manufacturing and R&D facilities across Asia, Europe and Americas. Lonza is headquartered in Basel, Switzerland.
Lonza Group Ltd Key Recent Developments
Feb 13,2019: Emerald Health Pharmaceuticals and Lonza announce agreement for manufacturing of novel cannabinoid-derived drug candidate
Feb 11,2019: Lonza's new pooled donor suspension hepatocytes enable the next level of reliability, robustness and customizability
Jan 31,2019: Lonza CEO Richard Ridlinger to Step Down This Year
Jan 30,2019: Lonza achieved another excellent full-year result in 2018 with 9% organic sales growth and strong profitability driven by healthcare businesses
Jan 30,2019: Lonza announces succession of CEO
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Lonza Group Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Zep Inc.
Sannitree International
Royal DSM NV
NBE-Therapeutics AG
Mabuhay Vinyl Corp
Dottikon ES Holding AG
Caladrius Biosciences Inc
BASF SE
Aliancys AG
Actelion Pharmaceuticals Ltd
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Lonza Group Ltd-Key Facts
Lonza Group Ltd-Key Employees
Lonza Group Ltd-Key Employee Biographies
Lonza Group Ltd-Key Operational Employees
Lonza Group Ltd-Major Products and Services
Lonza Group Ltd-History
Lonza Group Ltd-Company Statement
Lonza Group Ltd-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2-Company Analysis
Company Overview
Lonza Group Ltd-Business Description
Business Segment: Pharma & Biotech
Overview
Performance
Business Segment: Specialty Ingredients
Overview
Performance
R&D Overview
Lonza Group Ltd-Corporate Strategy
Lonza Group Ltd-SWOT Analysis
SWOT Analysis-Overview
Lonza Group Ltd-Strengths
Lonza Group Ltd-Weaknesses
Lonza Group Ltd-Opportunities
Lonza Group Ltd-Threats
Lonza Group Ltd-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Lonza Group Ltd, Recent Deals Summary
Section 5-Company's Recent Developments
Feb 13, 2019: Emerald Health Pharmaceuticals and Lonza announce agreement for manufacturing of novel cannabinoid-derived drug candidate
Feb 11, 2019: Lonza's new pooled donor suspension hepatocytes enable the next level of reliability, robustness and customizability
Jan 30, 2019: Lonza achieved another excellent full-year result in 2018 with 9% organic sales growth and strong profitability driven by healthcare businesses
Jan 30, 2019: Lonza announces succession of CEO
Jan 15, 2019: Lonza announces retirement of Fridtjof Helemann
Jan 08, 2019: The world's first fully automated plate-based robotic solution for high precision in endotoxin detection
Dec 10, 2018: Lonza to establish Strategic Biomanufacturing base in China using GE Healthcare Solution
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Lonza Group Ltd, Performance Chart (2014-2018)
Lonza Group Ltd, Ratio Charts
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Lonza Group Ltd, Key Facts
Lonza Group Ltd, Key Employees
Lonza Group Ltd, Key Employee Biographies
Lonza Group Ltd, Key Operational Employees
Lonza Group Ltd, Major Products and Services
Lonza Group Ltd, History
Lonza Group Ltd, Subsidiaries
Lonza Group Ltd, Joint Venture
Lonza Group Ltd, Key Competitors
Lonza Group Ltd, Annual Ratios
Lonza Group Ltd, Annual Ratios (Cont...1)
Lonza Group Ltd, Annual Ratios (Cont...2)
Lonza Group Ltd, Interim Ratios
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Lonza Group Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.